midazolam and oprozomib

midazolam has been researched along with oprozomib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cutler, RE; Gore, L; Harvey, RD; Mita, A; Ou, Y; Papadopoulos, KP; Pinchasik, DE; Tsimberidou, AM; Wang, Z; Xu, Y	1

Trials

1 trial(s) available for midazolam and oprozomib

Article	Year
Physiologically-based pharmacokinetic modelling to predict oprozomib CYP3A drug-drug interaction potential in patients with advanced malignancies. British journal of clinical pharmacology, 2019, Volume: 85, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Development; Drug Interactions; Female; Hepatocytes; Humans; Male; Microsomes, Liver; Midazolam; Middle Aged; Models, Biological; Neoplasms; Oligopeptides; Primary Cell Culture; Proteasome Inhibitors; Young Adult	2019

Article

Year

Physiologically-based pharmacokinetic modelling to predict oprozomib CYP3A drug-drug interaction potential in patients with advanced malignancies.

British journal of clinical pharmacology, 2019, Volume: 85, Issue:3

Topics: Adult; Aged; Aged, 80 and over; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Development; Drug Interactions; Female; Hepatocytes; Humans; Male; Microsomes, Liver; Midazolam; Middle Aged; Models, Biological; Neoplasms; Oligopeptides; Primary Cell Culture; Proteasome Inhibitors; Young Adult

2019